Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.7 EUR | 0.00% | +2.85% | -29.52% |
Apr. 25 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
Sales 2024 * | 60.73M 65.23M | Sales 2025 * | 70.75M 75.98M | Capitalization | 701M 753M |
---|---|---|---|---|---|
Net income 2024 * | -12M -12.89M | Net income 2025 * | 11M 11.81M | EV / Sales 2024 * | 10.4 x |
Net cash position 2024 * | 70.67M 75.9M | Net cash position 2025 * | 74.87M 80.41M | EV / Sales 2025 * | 8.85 x |
P/E ratio 2024 * |
-73.5
x | P/E ratio 2025 * |
518
x | Employees | 224 |
Yield 2024 * |
-
| Yield 2025 * |
0.61% | Free-Float | 42.17% |
1 day | -0.13% | ||
1 week | +2.72% | ||
Current month | -14.35% | ||
1 month | -12.75% | ||
3 months | -19.64% | ||
6 months | -25.52% | ||
Current year | -29.61% |
Managers | Title | Age | Since |
---|---|---|---|
Stefan Glombitza
CEO | Chief Executive Officer | - | 16-09-30 |
Enno Spillner
DFI | Director of Finance/CFO | 55 | 23-03-31 |
Andreas Seidl
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Olaf Stiller
FOU | Founder | 47 | 06-12-31 |
Peter Wendeln
BRD | Director/Board Member | 59 | - |
Klaus Röhrig
BRD | Director/Board Member | 47 | 20-12-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 17 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 39.75 | +0.13% | 668 |
24-04-25 | 39.7 | +1.53% | 5,054 |
24-04-24 | 39.1 | 0.00% | 6,386 |
24-04-23 | 39.1 | +2.36% | 16,546 |
24-04-22 | 38.2 | -1.16% | 24,448 |
Delayed Quote Xetra, April 26, 2024 at 03:02 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.61% | 751M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.13% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- FYB Stock